20-3889480-G-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001386393.1(PANK2):​c.50G>T​(p.Gly17Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000809 in 1,493,912 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00067 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00082 ( 13 hom. )

Consequence

PANK2
NM_001386393.1 missense

Scores

1
8
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.08
Variant links:
Genes affected
PANK2 (HGNC:15894): (pantothenate kinase 2) This gene encodes a protein belonging to the pantothenate kinase family and is the only member of that family to be expressed in mitochondria. Pantothenate kinase is a key regulatory enzyme in the biosynthesis of coenzyme A (CoA) in bacteria and mammalian cells. It catalyzes the first committed step in the universal biosynthetic pathway leading to CoA and is itself subject to regulation through feedback inhibition by acyl CoA species. Mutations in this gene are associated with HARP syndrome and pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome. Alternative splicing, involving the use of alternate first exons, results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008071929).
BP6
Variant 20-3889480-G-T is Benign according to our data. Variant chr20-3889480-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 285843.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-3889480-G-T is described in Lovd as [Benign]. Variant chr20-3889480-G-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00067 (102/152318) while in subpopulation SAS AF= 0.00952 (46/4830). AF 95% confidence interval is 0.00734. There are 0 homozygotes in gnomad4. There are 53 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 13 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PANK2NM_001386393.1 linkc.50G>T p.Gly17Val missense_variant Exon 1 of 7 ENST00000610179.7 NP_001373322.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PANK2ENST00000610179.7 linkc.50G>T p.Gly17Val missense_variant Exon 1 of 7 1 NM_001386393.1 ENSP00000477429.2 Q9BZ23-4

Frequencies

GnomAD3 genomes
AF:
0.000657
AC:
100
AN:
152204
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00931
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00173
AC:
167
AN:
96748
Hom.:
2
AF XY:
0.00204
AC XY:
111
AN XY:
54466
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000297
Gnomad ASJ exome
AF:
0.00114
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00795
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000697
Gnomad OTH exome
AF:
0.00176
GnomAD4 exome
AF:
0.000824
AC:
1106
AN:
1341594
Hom.:
13
Cov.:
78
AF XY:
0.00104
AC XY:
684
AN XY:
660158
show subpopulations
Gnomad4 AFR exome
AF:
0.000177
Gnomad4 AMR exome
AF:
0.000289
Gnomad4 ASJ exome
AF:
0.000505
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00829
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000368
Gnomad4 OTH exome
AF:
0.00109
GnomAD4 genome
AF:
0.000670
AC:
102
AN:
152318
Hom.:
0
Cov.:
34
AF XY:
0.000712
AC XY:
53
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.0000721
Gnomad4 AMR
AF:
0.000719
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00952
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000559
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.000505
Hom.:
1
Bravo
AF:
0.000487
ExAC
AF:
0.00153
AC:
158
Asia WGS
AF:
0.00260
AC:
9
AN:
3474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pigmentary pallidal degeneration Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Jun 01, 2020
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Has not been previously published as pathogenic or benign to our knowledge In silico analysis supports that this missense variant does not alter protein structure/function -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

PANK2: PP3, BS2 -

not specified Benign:1
Jan 29, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

PANK2-related disorder Benign:1
Aug 07, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.22
T;.
Eigen
Benign
0.14
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.80
T;T
MetaRNN
Benign
0.0081
T;T
MetaSVM
Uncertain
0.76
D
MutationAssessor
Benign
0.0
N;.
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-0.51
N;.
REVEL
Uncertain
0.46
Sift
Uncertain
0.0050
D;.
Sift4G
Uncertain
0.020
D;D
Polyphen
0.61
P;.
Vest4
0.43
MVP
0.98
MPC
0.62
ClinPred
0.083
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.22
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs528149001; hg19: chr20-3870127; API